Accéder au contenu
Merck

CAR expression in human embryos and hESC illustrates its role in pluripotency and tight junctions.

Reproduction (Cambridge, England) (2014-08-15)
M Krivega, M Geens, H Van de Velde
RÉSUMÉ

Coxsackie virus and adenovirus receptor, CXADR (CAR), is present during embryogenesis and is involved in tissue regeneration, cancer and intercellular adhesion. We investigated the expression of CAR in human preimplantation embryos and embryonic stem cells (hESC) to identify its role in early embryogenesis and differentiation. CAR protein was ubiquitously present during preimplantation development. It was localised in the nucleus of uncommitted cells, from the cleavage stage up to the precursor epiblast, and corresponded with the presence of soluble CXADR3/7 splice variant. CAR was displayed on the membrane, involving in the formation of tight junction at compaction and blastocyst stages in both outer and inner cells, and CAR corresponded with the full-length CAR-containing transmembrane domain. In trophectodermal cells of hatched blastocysts, CAR was reduced in the membrane and concentrated in the nucleus, which correlated with the switch in RNA expression to the CXADR4/7 and CXADR2/7 splice variants. The cells in the outer layer of hESC colonies contained CAR on the membrane and all the cells of the colony had CAR in the nucleus, corresponding with the transmembrane CXADR and CXADR4/7. Upon differentiation of hESC into cells representing the three germ layers and trophoblast lineage, the expression of CXADR was downregulated. We concluded that CXADR is differentially expressed during human preimplantation development. We described various CAR expressions: i) soluble CXADR marking undifferentiated blastomeres; ii) transmembrane CAR related with epithelial-like cell types, such as the trophectoderm (TE) and the outer layer of hESC colonies; and iii) soluble CAR present in TE nuclei after hatching. The functions of these distinct forms remain to be elucidated.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Formaldéhyde solution, for molecular biology, 36.5-38% in H2O
SAFC
Formaldéhyde solution, contains 10-15% methanol as stabilizer, 37 wt. % in H2O
Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
Formaldéhyde solution, for molecular biology, BioReagent, ≥36.0% in H2O (T)
Sigma-Aldrich
Formaldéhyde solution, ACS reagent, 37 wt. % in H2O, contains 10-15% Methanol as stabilizer (to prevent polymerization)
Supelco
Formaldéhyde solution, stabilized with methanol, ~37 wt. % in H2O, certified reference material
Sigma-Aldrich
Formaldéhyde solution, meets analytical specification of USP, ≥34.5 wt. %
Sigma-Aldrich
Activin A human, recombinant, expressed in E. coli, ≥97% (SDS-PAGE), ≥97% (HPLC), suitable for cell culture
Sigma-Aldrich
BMP-4 human, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
Sigma-Aldrich
Activin A human, ≥95% (SDS-PAGE), recombinant, expressed in baculovirus infected insect cells, lyophilized powder, suitable for cell culture
Sigma-Aldrich
Anti-Vimentin antibody, Mouse monoclonal, clone V9, purified from hybridoma cell culture
Sigma-Aldrich
Formaldéhyde solution, tested according to Ph. Eur.
Sigma-Aldrich
Activin A human, recombinant, expressed in HEK 293 cells, HumanKine®, suitable for cell culture
Sigma-Aldrich
Formaldehyde-12C solution, 20% in H2O, 99.9 atom % 12C
Sigma-Aldrich
BMP-4 human, recombinant, expressed in HEK 293 cells, ≥95% (SDS-PAGE)
Sigma-Aldrich
Activin A active human, Animal-component free, recombinant, expressed in Nicotiana, >97% (SDS-PAGE)
Sigma-Aldrich
Anti-CXADR antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution